Three New Products Released Today, With Six More on the Horizon
MELBOURNE, Fla., Feb. 6, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG), a prominent Biotech company, proudly announces a major breakthrough in research and development efforts, leading the pack on new procedures for the extraction and refinement of kavalactones. In addition, The Alcannabist LLC, a wholly owned subsidiary of Branded Legacy , announced the official release of its new line of groundbreaking products designed to address diverse health and wellness needs.
CEO Dave Oswald had this to say about recent developments in the lab: "In the past, other companies were only scratching the surface in their efforts to extract and refine kavalactones. Prior to our team taking on the challenge of producing a superior product, the best the market had to offer was a decent purity level with an inconsistent opaque appearance. We were able to make a high purity extract that was completely translucent and very flavorful on the first day. When we presented our extract to our kava suppliers, they asked to move forward immediately with a white label contract. Needless to say, we are very excited about the potential of these developments."
The Alcannabist's new products, which include: VapeRx Anti Anxiety, ElixRx Migraine/Headache Support, and Mood Mix Capsules, are now officially on the market. This marks a significant expansion of The Alcannabist's product offerings. Three of their six new products, (VapeRx Plus Kava Anti Anxiety Rescue, VapeRx Plus Kava Sleep, and VapeRx Plus Kava Pain Management), will be added to their VapeRx line in the coming weeks. The other three, ElixRx Plus Kava Anti Anxiety, ElixRx Plus Kava Sleep, and ElixRx Plus Kava Pain Management, will be included in their ElixRx line. These products will be the first of many additions to their soon to be released Kava Plus family of therapeutics.
Joseph Holladay, Chief Operating Officer of Branded Legacy, and one of the principal developers of these products, expressed excitement about the new Kava Plus product lineup, stating, "Our team is dedicated to developing innovative solutions that cater to diverse wellness needs. These new Kava Plus products represent a significant step forward in our commitment to providing effective and accessible options for our customers. The Kava Plus line is one that I'm particularly excited about. We had great feedback on our CBD based sleep, pain and anxiety products, but we feel the addition of Kava has the ability to supercharge them for many of our customers, and the response we've gotten so far has surpassed our expectations."
Newly Released Products:
VapeRx Anti Anxiety Rescue: A revolutionary CBD vape, carefully crafted to provide relief from anxiety. This product leverages the calming properties of CBD and scientifically derived combination of terpenes to offer users a soothing and calm state of mind.
ElixRx Migraine: Specifically formulated to address headaches and migraines, ElixRx Migraine offers targeted relief with a proprietary blend of terpenes and cannabinoids designed to alleviate all types of headaches.
Mood Mix Capsules: Mood Mix introduces a mitragynine product in convenient 25ml powder capsules, offering users a unique and controlled way to incorporate this botanical substance into their wellness routines. Mood Mix is formulated to improve mood, alleviate pain, and provide a sustained energy boost.
Upcoming Product Releases:
VapeRx Plus Kava Anti Anxiety Rescue, VapeRx Plus Kava Sleep, and VapeRx Plus Kava Pain Management: Soon to be launched, these vapable CBD plus Kava products aim to enhance the anti-anxiety effects, promote restful sleep, and manage pain effectively.
ElixRx Plus Kava Anti Anxiety, ElixRx Plus Kava Sleep, and ElixRx Plus Kava Pain Management: Expected to be available shortly, these ElixRx Plus Kava products will offer a comprehensive and sustained approach to anti-anxiety, sleep aid, and pain management.
Branded Legacy remains at the forefront of the industry, continually pushing the boundaries of CBD and botanical-based products. With a focus on quality, safety, and efficacy, the company strives to make a positive impact on its customers, employees, and shareholders. In a proactive move to strengthen the company's financial position and enhance shareholder value, Branded Legacy, Inc. recently negotiated the purchase of outstanding debt of $1,500,000 at a remarkable price of $450,000. This strategic decision not only eliminates a substantial liability but also safeguards against any potential conversion of the debt into shares. With a commitment to fiscal responsibility, a relentless pursuit of useful alkaloids, and a dedicated product development team, stay tuned for the continued release of many outstanding products.
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services. The company's diverse portfolio includes ventures in biotechnology, digital solutions, and wellness products, all aimed at enhancing the quality of life for its customers. Branded Legacy's strategic approach to growth involves identifying and integrating promising businesses and technologies that align with its mission to deliver sustainable, high-quality products and services.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.
